Fast updates from the world of phages, viromes, and microbiome science.
Factors governing phage replication and phage transmission in situ are unknown, especially within the confines of the gastrointestinal tract. We are unaware of the consequences of…
BiomX, a company developing natural and engineered phages, has announced positive results in clinical trials. BiomX has announced the safety and efficacy results from the Phase…
Phages—viruses that specifically target and eliminate bacteria—offer a highly targeted approach to infection control, reducing the risk of harming beneficial microbiota. With the “silent pandemic” of…
The Targeting Phage Therapy organization has announced the 8th World Conference which will be held on June 10-11, 2025 at DoubleTree by Hilton Berlin Kudamm, Berlin,…
Two phage-based vaccine candidates for avian influenza (H5N1) developed by Cytophage are now entering preclinical trials. Cytophages’ innovative phage technology uses distinct antigen presentation strategies to…
“The Phage Art Competition, 2024” comes to an end and The Phage is excited to announce the finalists. The Competition began on 1-December-2024 and the submission…
The Phage Genome Analysis and Comparative Genomics Workshop hosted by the Phage Hunters Training and Research Program conducted for 10 days in February 2025 at the…
Over the past 100 years, antibiotics have drastically changed modern medicine. “The introduction of antibiotics into clinical use was arguably the greatest medical breakthrough of the…
PACE (Pathways to Antimicrobial Clinical Efficacy) is one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery. PACE helps to fast-track the…
Brussels, Belgium – In a landmark move for the advancement of phage technology, three pioneering companies—Proteon Pharmaceuticals, JAFRAL, and PTC Phage Technology Center—have officially established PhageEU…